Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2024;35(1):143-9
Article Links
Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus Erythematosus
Herwinda Brahmanti1, Cesarius Singgih Wahono2, Mirza Zaka Pratama2, Perdana Aditya Rahman2, Riski Bagus Suhendra1, Amalia Novia Rizky1, Nabilah Hanifah Mukti1
Authors Information

1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Brawijaya – RSUD dr. Saiful Anwar Malang, Indonesia

2Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya – RSUD dr. Saiful Anwar Malang, Indonesia

Herwinda Brahmanti, Cesarius Singgih Wahono, Mirza Zaka Pratama, Perdana Aditya Rahman, Riski Bagus Suhendra, Amalia Novia Rizky, Nabilah Hanifah Mukti

Keywords: cutaneous manifestation, systemic lupus erythematosus, disease activity, cutaneous lupus
References
  1. Cooper EE, Pisano CE, Shapiro SC. Cutaneous Manifestations of "Lupus": Systemic Lupus Erythematosus and Beyond. Int J Rheumatol 2021 May 18;2021:6610509.
  2. Veimern CA, Sungkar E, Dharmadji HP, Hamijoyo L. Mucocutaneous Manifestation of Systemic Lupus Erythematosus Patients at Rheumatology Outpatient Clinic in Dr. Hasan Sadikin General Hospital. Indones J Rheumatol 2017;9(1):17–20.
  3. Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 2022 Oct 14:ard-2022-223035.
  4. Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 2017 Aug;13(8):799-814.
  5. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 2017 Nov 1;56(11):1945-1961.
  6. Wu MY, Wang CH, Ng CY, Kuo TT, Chang YC, Yang CH, Lin JY, Ho HC, Chung WH, Chen CB. Periorbital erythema and swelling as a presenting sign of lupus erythematosus in tertiary referral centers and literature review. Lupus 2018 Oct;27(11):1828-37.
  7. Sitohang IBS, Rheza AM, Sirait SP, Fitri EM, Suseno LS. Acne Vulgaris Mimicking Cutaneous Lupus Erythematosus in an Adolescent: Report of a Rare Case. Case Rep Dermatol 2021 Feb 1;13(1):69-74.
  8. Stull C, Sprow G, Werth VP. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist. J Rheumatol 2022 Sep 15:jrheum.220089.
  9. Aringer M, Costenbader K, Dörner T, Johnson SR. Advances in SLE classification criteria. J Autoimmun 2022 Oct;132:102845.
  10. Ribero S, Sciascia S, Borradori L, Lipsker D. The Cutaneous Spectrum of Lupus Erythematosus. Clin Rev Allergy Immunol 2017 Dec;53(3):291-305.
  11. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981 Apr;4(4):471-5.
  12. Goldman N, Han J, LaChance A. Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases. Clin Cosmet Investig Dermatol 2022 Oct 26;15:2285-312.
  13. Jarrett P, Thornley S, Scragg R. Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus 2016 Nov;25(13):1497-502.
  14. Ker KJ, Teske NM, Feng R, Chong BF, Werth VP. Natural history of disease activity and damage in patients with cutaneous lupus erythematosus. J Am Acad Dermatol 2018 Dec;79(6):1053-1060.e3.
  15. Del Barrio-Díaz P, Reyes-Vivanco C, Cifuentes-Mutinelli M, Manríquez J, Vera-Kellet C. Association between oral lesions and disease activity in lupus erythematosus. J Eur Acad Dermatol Venereol 2020 Feb;34(2):349-56.
  16. Aringer M. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum 2019 Dec;49(3S):S14-S17.
  17. Uribe AG, Vilá LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcón GS. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 2004 Oct;31(10):1934-40.
  18. Handono K, Wahono CS, Pratama MZ, Kalim H. Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus. Lupus 2021 Oct;30(12):1906-14.
  19. Kalim H, Pratama MZ, Mahardini E, Winoto ES, Krisna PA, Handono K. Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients. Int J Rheum Dis 2020 May;23(5):620-6.
  20. Chanprapaph K, Tubtieng I, Pratumchat N, Thadanipon K, Rattanakaemakorn P, Suchonwanit P. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients. Lupus 2021 Apr;30(5):785-94.
  21. Medlin JL, Hansen KE, Fitz SR, Bartels CM. A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus. Semin Arthritis Rheum 2016 Jun;45(6):691-7.
  22. Drucker AM, Su J, Mussani F, Siddha SK, Gladman DD, Urowitz MB. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study. Lupus 2016 Apr;25(4):376-81.
  23. Zecević RD, Vojvodić D, Ristić B, Pavlović MD, Stefanović D, Karadaglić D. Skin lesions--an indicator of disease activity in systemic lupus erythematosus? Lupus 2001;10(5):364-7.
  24. Chanprapaph K, Tankunakorn J, Suchonwanit P, Rutnin S. Dermatologic Manifestations, Histologic Features and Disease Progression among Cutaneous Lupus Erythematosus Subtypes: A Prospective Observational Study in Asians. Dermatol Ther (Heidelb) 2021 Feb;11(1):131-47.
  25. Koubar SH, Kort J, Kawtharani S, Chaaya M, Makki M, Uthman I. Characteristics of lupus and lupus nephritis at a tertiary care center in Lebanon. Lupus 2019 Nov;28(13):1598-603.
  26. Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus 2019 Jul;28(8):1021-6.
  27. Tarazi M, Gaffney RG, Pearson D, Kushner CJ, Werth VP. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases. Br J Dermatol 2019 Jun;180(6):1468-72.
  28. Consani Fernández SA, Díaz Cuña CL, Fernández Rey L, Rostán Sellanes S, Maciel Oleggini G, Facal Castro JA. Infections in systemic autoimmune diseases. Reumatol Clin (Engl Ed) 2021 Dec;17(10):582-7.
  29. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M. Infection in systemic lupus erythematosus. J Med Assoc Thai 1993 Oct;76(10):542-8.
  30. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003 Sep;15(5):528-34.
  31. Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011. Arthritis Care Res (Hoboken) 2015 Aug;67(8):1078-85.
  32. Mok CC, Tse SM, Chan KL, Ho LY. Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies. Lupus 2020 Jul;29(8):836-44.
  33. Singh BK, Singh S. Systemic lupus erythematosus and infections. Reumatismo 2020 Nov 19;72(3):154-69.